These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32213720)

  • 1. Roxadustat Markedly Reduces Myocardial Ischemia Reperfusion Injury in Mice.
    Deguchi H; Ikeda M; Ide T; Tadokoro T; Ikeda S; Okabe K; Ishikita A; Saku K; Matsushima S; Tsutsui H
    Circ J; 2020 May; 84(6):1028-1033. PubMed ID: 32213720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
    Neckář J; Hsu A; Hye Khan MA; Gross GJ; Nithipatikom K; Cyprová M; Benák D; Hlaváčková M; Sotáková-Kašparová D; Falck JR; Sedmera D; Kolář F; Imig JD
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1148-H1158. PubMed ID: 30074840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation.
    Miao AF; Liang JX; Yao L; Han JL; Zhou LJ
    Ren Fail; 2021 Dec; 43(1):803-810. PubMed ID: 33966598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.
    Del Balzo U; Signore PE; Walkinshaw G; Seeley TW; Brenner MC; Wang Q; Guo G; Arend MP; Flippin LA; Chow FA; Gervasi DC; Kjaergaard CH; Langsetmo I; Guenzler V; Liu DY; Klaus SJ; Lin A; Neff TB
    J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat (FG-4592) alleviates sepsis-induced acute lung injury.
    Han F; Wu G; Han S; Li Z; Jia Y; Bai L; Li X; Wang K; Yang F; Zhang J; Wang X; Guan H; Linlin S; Han J; Hu D
    Respir Physiol Neurobiol; 2020 Oct; 281():103506. PubMed ID: 32726645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury.
    Yang Y; Yu X; Zhang Y; Ding G; Zhu C; Huang S; Jia Z; Zhang A
    Clin Sci (Lond); 2018 Apr; 132(7):825-838. PubMed ID: 29581249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.
    Mäkinen S; Sree S; Ala-Nisula T; Kultalahti H; Koivunen P; Koistinen HA
    Diabetologia; 2024 Sep; 67(9):1943-1954. PubMed ID: 38814443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panax Notoginseng Saponins Attenuate Myocardial Ischemia-Reperfusion Injury Through the HIF-1α/BNIP3 Pathway of Autophagy.
    Liu XW; Lu MK; Zhong HT; Wang LH; Fu YP
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):92-99. PubMed ID: 30531436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.
    Ong SG; Lee WH; Theodorou L; Kodo K; Lim SY; Shukla DH; Briston T; Kiriakidis S; Ashcroft M; Davidson SM; Maxwell PH; Yellon DM; Hausenloy DJ
    Cardiovasc Res; 2014 Oct; 104(1):24-36. PubMed ID: 25063991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
    Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
    Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roxadustat Attenuates Adverse Remodeling Following Myocardial Infarction in Mice.
    Zaruba MM; Staggl S; Ghadge SK; Maurer T; Gavranovic-Novakovic J; Jeyakumar V; Schönherr P; Wimmer A; Pölzl G; Bauer A; Messner M
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
    J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carthamin Yellow Protects the Heart Against Ischemia/Reperfusion Injury With Reduced Reactive Oxygen Species Release and Inflammatory Response.
    Lu QY; Ma JQ; Duan YY; Sun Y; Yu S; Li B; Zhang GM
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):228-234. PubMed ID: 31356540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protectin D1 Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating PI3K/AKT Signaling Pathway.
    Zhang P; Wang J; Wang X; Wang L; Xu S; Gong P
    J Cardiovasc Transl Res; 2024 Apr; 17(2):376-387. PubMed ID: 37580643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roxadustat attenuates experimental pulmonary fibrosis in vitro and in vivo.
    Huang H; Wang X; Zhang X; Wang H; Jiang W
    Toxicol Lett; 2020 Oct; 331():112-121. PubMed ID: 32534005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway.
    Gu J; Fan Y; Liu X; Zhou L; Cheng J; Cai R; Xue S
    Cardiovasc Res; 2014 Oct; 104(1):83-92. PubMed ID: 25082844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes.
    Rane S; He M; Sayed D; Vashistha H; Malhotra A; Sadoshima J; Vatner DE; Vatner SF; Abdellatif M
    Circ Res; 2009 Apr; 104(7):879-86. PubMed ID: 19265035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Mixed Lymphocyte Reaction, the Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat Suppresses Cellular and Humoral Alloimmunity.
    Eleftheriadis T; Pissas G; Mavropoulos A; Nikolaou E; Filippidis G; Liakopoulos V; Stefanidis I
    Arch Immunol Ther Exp (Warsz); 2020 Oct; 68(6):31. PubMed ID: 33011826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
    Xie L; Pi X; Wang Z; He J; Willis MS; Patterson C
    J Mol Cell Cardiol; 2015 Mar; 80():156-65. PubMed ID: 25633836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism.
    Madai S; Kilic P; Schmidt RM; Bas-Orth C; Korff T; Büttner M; Klinke G; Poschet G; Marti HH; Kunze R
    Theranostics; 2024; 14(7):2856-2880. PubMed ID: 38773968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.